{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Genetics&page=31", "query": { "condition": "Cancer Genetics", "page": 31 }, "page_size": 10 }, "pagination": { "page": 31, "page_size": 10, "total_count": 1625, "total_pages": 163, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Genetics&page=32&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Genetics&page=30&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T23:52:59.976Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04148651", "title": "The CO2RE® System for Vulvar Lichen Sclerosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vulvar Lichen Sclerosus" ], "interventions": [ { "name": "The CO2RE® System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Candela Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "18 Years to 80 Years · Female only" }, "enrollment_count": 14, "start_date": "2018-07-11", "completion_date": "2020-12-17", "has_results": true, "last_update_posted_date": "2022-03-22", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 4, "location_summary": "Jacksonville, Florida • Cincinnati, Ohio • South Burlington, Vermont", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "South Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT04148651" }, { "nct_id": "NCT02272595", "title": "Rational Therapeutics Based on Matched Tumor and Normal Tissue", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Cancers" ], "interventions": [ { "name": "Treatment Based on Genetic Mutation", "type": "OTHER" }, { "name": "Treatment Based on No Genetic Mutation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2014-11-04", "completion_date": "2022-01-11", "has_results": false, "last_update_posted_date": "2022-02-15", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02272595" }, { "nct_id": "NCT01956773", "title": "Family Health History in Diverse Care Settings (FHH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes", "Heart Disease", "Cancer" ], "interventions": [ { "name": "MeTree", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2620, "start_date": "2014-04-11", "completion_date": "2017-10-31", "has_results": true, "last_update_posted_date": "2023-08-02", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 5, "location_summary": "Fairfield, California • Duluth, Minnesota • Durham, North Carolina + 2 more", "locations": [ { "city": "Fairfield", "state": "California" }, { "city": "Duluth", "state": "Minnesota" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Fort Worth", "state": "Texas" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01956773" }, { "nct_id": "NCT04976803", "title": "Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Solid Tumor, Unspecified, Adult" ], "interventions": [ { "name": "Determination of ATM alteration status.", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Artios Pharma Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 229, "start_date": "2021-05-28", "completion_date": "2022-06-30", "has_results": false, "last_update_posted_date": "2022-08-01", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 2, "location_summary": "Oklahoma City, Oklahoma • Nashville, Tennessee", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04976803" }, { "nct_id": "NCT05006131", "title": "Pancreatic Cancer Screening for At-risk Individuals", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Cancer, Adult" ], "interventions": [ { "name": "Screening for pancreatic cancer", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 1395, "start_date": "2020-07-10", "completion_date": "2032-12-31", "has_results": false, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05006131" }, { "nct_id": "NCT03544983", "title": "Genetic Education in BRCA Families", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "BRCA1 Mutation", "BRCA2 Mutation" ], "interventions": [ { "name": "Web + Streamlined Telephone Genetic Information", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 240, "start_date": "2020-05-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 4, "location_summary": "Washington D.C., District of Columbia • Boston, Massachusetts • Danville, Pennsylvania", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Danville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03544983" }, { "nct_id": "NCT05768139", "title": "First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Breast Cancer", "Solid Tumors, Adult" ], "interventions": [ { "name": "STX-478", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Exemestane", "type": "DRUG" }, { "name": "Tamoxifen", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Imlunestrant", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 880, "start_date": "2023-04-17", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 28, "location_summary": "Los Angeles, California • San Francisco, California • Aurora, Colorado + 22 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Lake Mary", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05768139" }, { "nct_id": "NCT00002611", "title": "Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney Cancer" ], "interventions": [ { "name": "dactinomycin", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "0 Years to 15 Years" }, "enrollment_count": 3031, "start_date": "1995-07", "completion_date": "2003-08", "has_results": false, "last_update_posted_date": "2021-02-25", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 206, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 151 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002611" }, { "nct_id": "NCT03672838", "title": "A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neurofibromatosis 1 and 2 (NF1 and NF2)" ], "interventions": [ { "name": "hand-held dynamometer", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 33, "start_date": "2018-09-24", "completion_date": "2019-12-02", "has_results": false, "last_update_posted_date": "2021-03-18", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03672838" }, { "nct_id": "NCT06210698", "title": "Angioedema Biomarker Research Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Angioedema", "Angioedemas, Hereditary", "Urticaria", "Mastocytosis", "ACE Inhibitor-Induced Angioedema", "C1 Inhibitor Deficiency", "Systemic Mastocytoses", "Indolent Systemic Mastocytosis" ], "interventions": [ { "name": "Venipuncture", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Foundation For Rare Disease Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 600, "start_date": "2024-01-15", "completion_date": "2027-08-01", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-10-30T23:52:59.976Z", "location_count": 1, "location_summary": "Wheaton, Maryland", "locations": [ { "city": "Wheaton", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06210698" } ] }